Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Sep 21, 2022

Accession no.
0001209191-22-050817
Filed
Sep 21, 2022, 7:23 AM ET
Trade date
Sep 20, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market purchases total $96.9K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 20, 2022Common StockPPurchaseAcquired+4,700$1.93+$9,047.5197,511,394Indirect
Sep 20, 2022Common StockPPurchaseAcquired+9,200$1.93+$17,756197,520,594Indirect
Sep 20, 2022Common StockPPurchaseAcquired+5,956$1.94+$11,524.86197,526,550Indirect
Sep 20, 2022Common StockPPurchaseAcquired+20,200$1.94+$39,188197,546,750Indirect
Sep 20, 2022Common StockPPurchaseAcquired+3,900$1.95+$7,585.5197,550,650Indirect
Sep 20, 2022Common StockPPurchaseAcquired+6,044$1.95+$11,785.8197,556,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)